NCIt definition : A toll-like receptor type 7 and 8 (TLR7/8) agonist, with potential immunostimulating
and antineoplastic activities. Upon administration, TLR7/8 agonist EIK1001 targets,
binds to and activates TLR7 and 8, thereby activating TLR7/8-mediated pathways. This
stimulates the maturation and activation of antigen-presenting cells (APCs), including
dendritic cells (DCs). Activation of DCs results in the production of pro-inflammatory
cytokines, and the activation of cytotoxic T-lymphocyte (CTL)- and B-lymphocyte-mediated
immune responses. This may lead to tumor cell lysis. TLR7 and 8, members of the TLR
family, play fundamental roles in the activation of the innate immune system, myeloid
cell responses and tumor antigen presentation.;
Molecule name : BDB-001; BDB 001; EIK 1001; EIK-1001;